CC News and Press, Chemours Company From 10/05/22

Chemours ( NYSE: CC ) on Wednesday was downgraded to Hold from Buy by analysts at Argus Research. The firm cited weaker economic conditions, rising costs of raw materials and falling demand for titanium dioxide for the rating change. Chemours two weeks ago cut its EBITDA and...

The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, announced it will release third quarter 2022 financial results after ma...

Summary CC was spun out of DuPont in 2015. They have been free cash flow positive since 2016. There is no differentiator as far as quality or price multiples. The Chemours Company (CC) was spun out of DuPont ( DD ) in 2015. Its four segments are titanium technologies...

Chemours ( NYSE: CC ) +6.2% in Monday's trading after saying it will spend $200M to increase capacity and advance technology for its Nafion ion exchange materials to support rising demand for hydrogen power. Chemours ( CC ) said its investment "will support growi...

Investment in Nafion™ membranes and dispersions will enable clean energy generation and storage in applications ranging from large-scale power systems to the automobiles of the future The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leadin...

Summary I wrote about Chemours a few months back, calling the company a "BUY" - shortly after that, the market dropped, and the company is down significantly more today. While it remains impossible to forecast market trends, I do remain confident in the long-term upside for Chemou...

Summary Prices of refrigerants should stay elevated for the foreseeable future as there is a rare bipartisan consensus among politicians to sharply curtail the supply of certain refrigerants. This artificial supply shortage along with other tailwinds sets Hudson up very well to ma...

While the overall dour sentiment pervading the market is driving the S&P 500 toward a decline of more than 5% this week, investors are especially pessimistic about Chemours (NYSE: CC) . As of 2:05 p.m. ET, shares of Chemours are down 20.7% since the market's close last ...

Senate ratification elevates U.S. commitment to the health of the planet and establishes strong foundations for competitive advantage across multiple American businesses and industries The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company wit...

Chemours ( NYSE: CC ) -6.3% pre-market Wednesday, poised to open at a six-month low, after the company cut guidance for full-year adjusted EBITDA , citing a continuing decline in the demand outlook for its Titanium Technologies segment, especially in Europe and Asia, as ...